INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY

Published:2015-04 Issue:4 Volume:35 Page:667-674
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Chen San-Ni,Lian Iebin,Hwang Ya-Chi,Chen Yi-Hsing,Chang Yao-Chung,Lee Kun-Hsien,Chuang Chih-Chun,Wu Wei-Chi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference43 articles.

1. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.;Arch Ophthalmol,2003

2. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain.;Lu;Apoptosis,2006

3. Clinical anesthesia causes permanent damage to the fetal guinea pig brain.;Rizzi;Brain Pathol,2008

4. . Neurodevelopmental outcomes and surgery in neonates.;Walker;J Paediatr Child Health,2006

5. Educational attainments in early adolescence of infants who required major neonatal surgery.;Ludman;J Pediatr Surg,2001

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Six years follow-up of type 1 retinopathy of prematurity (ROP) treated with intravitreal injection of ranibizumab and bevacizumab: Long-Term Outcomes of intravitreal injection in Type 1 ROP;Medicine;2024-08-09

2. Special features of postoperative long-term follow-up patients with retinopathy of prematurity;Traditional Medicine and Modern Medicine;2024-07-03

3. Retinopathy of Prematurity (ROP)—Risk Factors and Therapeutic Effect of Intravitreal Injection of Bevacizumab (IVB): An Observational Study from a Neonatal Intensive Care Unit in Egypt;Dr. Sulaiman Al Habib Medical Journal;2024-04

4. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

5. Fluorescein Angiography Evaluation of Children Previously Treated with Anti-VEGF Monotherapy for Retinopathy of Prematurity;Retina;2023-12-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3